SALT LAKE CITY, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Seek Labs, a TechBio company building programmable platforms to decode, program, and resolve diseases, today announced the Open Impact Sequence Ablation Therapeutics Program, a new Commitment to Action through the Clinton…